Literature DB >> 30030072

Candida auris: An emerging drug resistant yeast - A mini-review.

A L Bidaud1, A Chowdhary2, E Dannaoui3.   

Abstract

Candida auris is an emerging fungal pathogen responsible for nosocomial invasive infection outbreaks on five continents. Large healthcare-related outbreaks of C. auris infection and colonization have been reported from different countries. Whole genome sequence analysis identified strong phylogeographic C. auris clades specific to particular geographical areas suggesting transmission of particular clades within countries. However, the mode of transmission within the healthcare environment is not clear and is likely to be multifactorial. The emergence of C. auris is alarming because this organism can harbor or develop multidrug resistance. This explains why C. auris infections are difficult to treat. In addition, difficulties in its identification in the routine diagnostic laboratory have a significant impact on outbreak detection and management. This mini-review highlights the available literature on C. auris, with particular insight into its epidemiology and the problems caused by its antifungal resistance.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Antifungal; Candida auris; Control strategy; Epidemiology; Multi-drug resistance; Prevention; Treatment

Mesh:

Substances:

Year:  2018        PMID: 30030072     DOI: 10.1016/j.mycmed.2018.06.007

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  31 in total

Review 1.  Candida auris: a fungus with identity crisis.

Authors:  Taissa Vila; Ahmed S Sultan; Daniel Montelongo-Jauregui; Mary Ann Jabra-Rizk
Journal:  Pathog Dis       Date:  2020-06-01       Impact factor: 3.166

2.  In vitro antifungal combination of flucytosine with amphotericin B, voriconazole, or micafungin against Candida auris shows no antagonism.

Authors:  A L Bidaud; F Botterel; A Chowdhary; E Dannaoui
Journal:  Antimicrob Agents Chemother       Date:  2019-10-07       Impact factor: 5.191

Review 3.  Candida auris, a singular emergent pathogenic yeast: its resistance and new therapeutic alternatives.

Authors:  Liliana Fernandes; Rita Ribeiro; Mariana Henriques; Maria Elisa Rodrigues
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2022-10-06       Impact factor: 5.103

4.  Comparative Transcriptomics Reveal Possible Mechanisms of Amphotericin B Resistance in Candida auris.

Authors:  Raju Shivarathri; Sabrina Jenull; Manju Chauhan; Ashutosh Singh; Rounik Mazumdar; Anuradha Chowdhary; Karl Kuchler; Neeraj Chauhan
Journal:  Antimicrob Agents Chemother       Date:  2022-06-02       Impact factor: 5.938

5.  A Selective Medium for Isolation and Detection of Candida auris, an Emerging Pathogen.

Authors:  Sourav Das; Shreya Singh; Yamini Tawde; Arunaloke Chakrabarti; Shivaprakash M Rudramurthy; Harsimran Kaur; Shamanth A Shankarnarayan; Anup Ghosh
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

6.  Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterization of Candida auris Detected in a Surveillance Program.

Authors:  Michael A Pfaller; Shawn A Messer; Lalitagauri M Deshpande; Paul R Rhomberg; Eric A Utt; Mariana Castanheira
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

Review 7.  Fungi in the indoor air of critical hospital areas: a review.

Authors:  Jenyffie A Belizario; Leonardo G Lopes; Regina H Pires
Journal:  Aerobiologia (Bologna)       Date:  2021-05-14       Impact factor: 2.410

Review 8.  Update on invasive fungal infections in the Middle Eastern and North African region.

Authors:  Marwan Osman; Aisha Al Bikai; Rayane Rafei; Hassan Mallat; Fouad Dabboussi; Monzer Hamze
Journal:  Braz J Microbiol       Date:  2020-07-05       Impact factor: 2.476

9.  Search for Promising Strains of Probiotic Microbiota Isolated from Different Biotopes of Healthy Cats for Use in the Control of Surgical Infections.

Authors:  Pavel Rudenko; Yuriy Vatnikov; Nadezhda Sachivkina; Andrei Rudenko; Evgeny Kulikov; Vladimir Lutsay; Elena Notina; Irina Bykova; Aleksander Petrov; Stanislav Drukovskiy; Ifarajimi Rapheal Olabode
Journal:  Pathogens       Date:  2021-05-28

10.  HECT E3 Ubiquitin Ligase Nedd4 Is Required for Antifungal Innate Immunity.

Authors:  Patrick K Nuro-Gyina; Na Tang; Hui Guo; Chengkai Yan; Qiuming Zeng; Thomas J Waldschmidt; Jian Zhang
Journal:  J Immunol       Date:  2021-07-19       Impact factor: 5.426

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.